{"id":"W4402890485","doi":"10.1177/17562864241281903","title":"Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Liraglutide; Semaglutide; Internal medicine; Mace; Overweight; Odds ratio; Diabetes mellitus; Type 2 diabetes; Placebo; Dulaglutide; Myocardial infarction; Population; Glucagon-like peptide 1 receptor; Endocrinology; Adverse effect; Obesity; Agonist; Receptor; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009750518,0.002198055,0.01686535,0.004553599,0.0004980448,0.00246165,0.00173069,0.001880344,0.002392753],"category_scores_gemma":[0.0201112,0.001417417,0.03493818,0.005267676,0.0006821745,0.001221893,0.001128257,0.001596232,0.0002260653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001849593,"about_ca_system_score_gemma":0.002382701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00472371,"about_ca_topic_score_gemma":0.01003448,"domain_scores_codex":[0.9928315,0.003150446,0.002149114,0.0008690209,0.0007894008,0.0002105338],"domain_scores_gemma":[0.9877423,0.007882752,0.002883256,0.0003364208,0.0009629201,0.0001922376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003353061,0.00003503808,0.005173545,0.3303055,0.6489049,0.0001114954,0.00006143953,0.0005334967,0.000265429,0.00009779723,0.0004576817,0.01070058],"study_design_scores_gemma":[0.0007822851,0.0002040523,0.003376802,0.01446418,0.9798682,0.00008058568,0.00002684651,0.0001623784,0.0001047088,0.0000947939,0.0008166097,0.00001845379],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008736663,0.9896214,0.0003687132,0.000162195,0.0001071628,0.0002005552,0.0005050523,0.00002122672,0.0002769496],"genre_scores_gemma":[0.2326413,0.7626373,0.001652682,0.0008046696,0.0002635738,0.0008364207,0.0008795728,0.00002658576,0.0002579825],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01686535,"threshold_uncertainty_score":0.05156624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06532569228572091,"score_gpt":0.3519981919897024,"score_spread":0.2866724997039815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}